ProfileGDS4718 / 220224_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 12% 13% 15% 15% 15% 9% 8% 12% 17% 10% 13% 10% 5% 10% 6% 10% 15% 20% 8% 15% 13% 11% 14% 22% 16% 7% 15% 12% 14% 10% 11% 11% 14% 20% 15% 13% 10% 13% 15% 12% 19% 14% 7% 3% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8541112
GSM549102patient 115, normal, homogenized [OPG study]3.9107113
GSM549104patient 119, normal, homogenized [OPG study]3.9186415
GSM549108patient 138, normal, homogenized [OPG study]3.9912515
GSM549119patient 077, normal, homogenized [OPG study]3.9714515
GSM549133patient 032, cancer, homogenized [OPG study]3.713659
GSM549139patient 042, cancer, homogenized [OPG study]3.698348
GSM549099patient 107, normal, homogenized [OPG study]3.8585812
GSM549109patient 139, normal, homogenized [OPG study]4.0486217
GSM549110patient 046, normal, homogenized [OPG study]3.7879910
GSM549114patient 063, normal, homogenized [OPG study]3.8717413
GSM549122patient 082, normal, homogenized [OPG study]3.7763610
GSM549134patient 033, cancer, homogenized [OPG study]3.598065
GSM549136patient 036, cancer, homogenized [OPG study]3.7532210
GSM549140patient 044, cancer, homogenized [OPG study]3.613146
GSM549111patient 047, normal, homogenized [OPG study]3.7543110
GSM549113patient 057, normal, homogenized [OPG study]3.9051415
GSM549132patient 031, cancer, homogenized [OPG study]4.1224720
GSM549137patient 038, cancer, homogenized [OPG study]3.706618
GSM549142patient 047, cancer, homogenized [OPG study]4.0185215
GSM549100patient 110, normal, homogenized [OPG study]3.8986513
GSM549107patient 135, normal, homogenized [OPG study]3.8093111
GSM549115patient 068, normal, homogenized [OPG study]3.883414
GSM549116patient 072, normal, homogenized [OPG study]4.2053922
GSM549120patient 078, normal, homogenized [OPG study]3.9783316
GSM549131patient 030, cancer, homogenized [OPG study]3.641397
GSM549118patient 074, normal, homogenized [OPG study]3.9721815
GSM549129patient 027, cancer, homogenized [OPG study]3.8670812
GSM549123patient 088, normal, homogenized [OPG study]3.9239714
GSM549124patient 006, cancer, homogenized [OPG study]3.7972510
GSM549126patient 015, cancer, homogenized [OPG study]3.7895211
GSM549128patient 025, cancer, homogenized [OPG study]3.7870311
GSM549103patient 117, normal, homogenized [OPG study]3.9558914
GSM549117patient 073, normal, homogenized [OPG study]4.1447520
GSM549138patient 041, cancer, homogenized [OPG study]3.9545215
GSM549141patient 045, cancer, homogenized [OPG study]3.8479713
GSM549130patient 028, cancer, homogenized [OPG study]3.7752910
GSM549101patient 111, normal, homogenized [OPG study]3.8933113
GSM549105patient 128, normal, homogenized [OPG study]3.9607315
GSM549106patient 134, normal, homogenized [OPG study]3.8056512
GSM549112patient 048, normal, homogenized [OPG study]4.1195319
GSM549125patient 011, cancer, homogenized [OPG study]3.936714
GSM549127patient 024, cancer, homogenized [OPG study]3.642047
GSM549135patient 035, cancer, homogenized [OPG study]3.437083